26041-53-2

Basic information

• Product Name: 2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
• Synonyms: 2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
• CAS NO: 26041-53-2
• Molecular Weight: 860.949
• Mol File: 26041-53-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid(26041-53-2)
• EPA Substance Registry System: 2-acetamido-3-[4-(4-acetoxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid(26041-53-2)

Safety Data

• Hazardous Substances Data: 26041-53-2(Hazardous Substances Data)

Upstream product

• 51-48-9 L-thyroxine 
• 108-24-7 acetic anhydride 

Relevant articles and documents

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof

Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric nanoparticle form of thyroid hormone agonist, partial agonist or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Nanoparticle forms of thyroid hormone or thyroid hormone analogs as well as uses thereof are also disclosed.

Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates

Several novel gadolinium chelates conjugated with paclitaxel, colchicine and thyroxine have been prepared as MRI contrast agents targeted to tubulin and thyroxine-binding globulin, respectively.